September: the virus strikes back

I still have not yet recovered blogging groove, as I settle down in my new home, and with family caring issues taking priority. So I am doing a consolidated look-back on the last month’s news again. If last time the central theme was the rise of Great Power politics, this time the theme is the virus.

After the Spring crisis passed, more or less, in the developed world (not so much in the US), people relaxed in the summer (or winter depending on your hemisphere). But the virus is coming back, with the world both better prepared, but less psychologically and economically resilient. The stress is showing.

The virus’s most spectacular victim was the US President. This drama is still playing out. What has emerged is interesting, though. Donald Trump has made a great show of not allowing the virus to affect him, being rarely seen in a mask. But in fact huge efforts are made to screen anybody that comes near him, with extensive use of a quick-turnaround test. But such measures only work so far, and if enough people come into proximity, the test is bound to have miss a few. A reception for his nominee for the Supreme Court appears to have been too hubristic.

Once Mr Trump was infected his behaviour stands in complete contrast to our own Boris Johnson. Mr Johnson soldiered on valiantly, did what the doctors told him, and went to a public hospital only when he had to, with treatment recognisably similar to any member of the public. Such a passive approach was not for Mr Trump. He quickly ordered the most aggressive treatment possible, and checked himself into and then out of an elite hospital. He now claims to have conquered the virus in days. We shall see. This probably reflects cultural differences between our two countries as much as personality. Many Americans, and especially the rich and powerful, struggle with the idea that they can’t take full control of their treatment, as is often the case with the UK’s NHS. Private treatment is available here, but, quite often the best expertise is tied to the public service, and Britons don’t like public and private to mix. It is one reason why nationalising health care is unpopular in the US, even if less well-off Americans have little practical control.

But what effect will this have on the US election campaign? Democrats continue to have reason for quiet confidence. A month ago they seemed a bit rattled, as Mr Trump had forced the narrative onto his own agenda: law and order. But the Democrats’ candidate, Joe Biden, is a seasoned campaigner, backed up by a solid team. He held his nerve. The riots subsided and soon the news was dominated by the death of Supreme Court Justice Ruth Bader Ginsburg, and the unseemly haste to replace her before the election. Mr Biden refused the invitation to stoke up the culture war on abortion, but instead moved the narrative on to court challenges to President Obama’s health care system, which many working class Americans now depend on. This was followed by the first TV debate, dominated by Mr Trump’s hyper=aggressive behaviour. Mr Biden was not given the rope to hang himself with, and the focus became the personality of the President, which the Democrats are quite happy with. And now Mr Trump’s infection has put the virus centre stage. Mr Biden’s poll lead seems to be holding up, and perhaps even increasing. Most Americans have chosen who they will vote for, and not a few have voted already. Everything that is happening seems to reinforcing those choices, on both sides, and making each side more motivated. As in the mid-term Congressional elections in 2018, that is mainly working for the Democrats. Can they seize the Senate?

But the biggest question to me is what will happen after the election, with the country so bitterly divided. Mr Trump doesn’t seem to care. But if Mr Biden wins, he will have a big job on his hands. He does seem to be aware of this.

Here in Britain, the UK government’s reputation is floundering. There is something curious about this. After its initial fumblings, and the appalling early death rate that resulted, the country’s record bears comparison with many of its peers. The record of the US is worse, and so is that of France, since June. Also the records of England (directly under the control of the UK government) and Scotland (mainly under the control of the devolved SNP government) is pretty similar. But Mr Johnson’s Conservatives have suffered much worse damage to their reputation. Mr Johnson’s style is ill-suited to the occasion, and, worse, he has surrounded himself with weak ministers, while more competent people remain on the sidelines criticising his record. There is a lot to criticise, of course, especially with the government’s failure to understand effective process management (with vastly inappropriate and over-centralised structures), and the lack of a clear strategy, as different factions vie to be heard. But others are making the same or worse mistakes and getting away with it. Mr Johnson is failing at the sorts of things politicians are supposed to be good at, as well as the ones for which they have little expertise. Many of theConservatives that voted Mr Johnson into office last year seem surprised; but most others are not.

So far the big winner from the crisis appears to be China. Although they too fumbled the early stages, with dire consequences for the rest of the world, their brand of totalitarian government has stamped out the disease and kept the virus at bay. Meanwhile everybody else is struggling: as they ease restrictions to let life go on as it should, the virus comes back, and the exponential dynamics of infectious diseases stoke. Still, some countries seem better able to handle the challenge than others. But it is hard to generalise. Herd immunity can be bought only at a very high price, in direct and indirect deaths, and debilitating “long-covid”, and may not last long-term anyway. But containment comes at a very high price too. A vaccine seems the best hope.